Close Menu
Home » Personal Genome Diagnostics Gets CE Mark for Elio Tissue Complete Assay

Personal Genome Diagnostics Gets CE Mark for Elio Tissue Complete Assay

Sep 25, 2019
|
staff reporter

NEW YORK – Personal Genome Diagnostics said today that it has successfully CE marked its PGDx Elio tissue complete assay, allowing the company to provide greater access to precision medicine for cancer patients in the European Union.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Project to Discuss Race and Genetics in Class

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

Taking It All On

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

PLOS Papers on ASD-Related Syndrome, Twin Gut Microbiomes, Zika Virus Evolution

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Dec
11
Featured Webinar

Advances in Precision Oncology: Tertiary Analysis Software for Solid Tumor NGS

Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials

  2. Veritas Genetics Halts US Operations, Lays Off More Than 30

  3. Beat AML Umbrella Trial Demonstrates Feasibility of Rapid Precision Medicine Approach

    Premium

  4. ASH Study: Germline Testing Identifies Cancer Risk Mutations, VUS in Older AML Patients

  5. Hologic Vaginitis Tests Offer Improvements Over Gold Standard Methods

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.